(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Wearable Devices Launches Mudra Band Preorders; Beamr Imaging Soars on NVIDIA's NVENC New Features; Dorian LPG Upgraded

May 25th, 2023

Wearable Devices Ltd. (Nasdaq: WLDS) has officially announced the availability of its flagship consumer product, the Mudra Band for Apple Watch, for preorder. This marks an exciting milestone for the company as it prepares for its first volume manufa. Read more

Analysts Bullish on SentinelOne, Mobileye Global, Carnival, Leidos Holdings and RenaissanceRe

May 25th, 2023

Raymond James has initiated coverage of SentinelOne, Inc. (NYSE: S) with a Strong Buy rating and set a price target of $25. During pre-market, $S is currently trading at $20.50, displaying an upward trend of $0.62 (+3.12%). Wells Fargo has init. Read more

Best Buy Beats Estimates, GDS Holdings Surprises with Narrowed-Than-Expected Loss, Nano Dimension's Bold Offer to Increase Stake in Stratasys

May 25th, 2023

Best Buy Co., Inc. (NYSE: BBY) has announced its financial results for the first quarter of fiscal year 2024, reporting earnings per share (EPS) of $1.15. This figure surpasses the consensus estimate of $1.11 per share. The company's sales performanc. Read more

Strong Q1 Financial Performances: X Financial, Lizhi, Siyata Mobile; Weibo Beats Estimates

May 25th, 2023

In the first quarter of 2023, X Financial (NYSE: XYF) showcased a strong financial performance, demonstrating its continued growth and success. The company's total net revenue reached an impressive RMB1,004.9 million, marking a year-over-year increas. Read more

Splunk, ePlus and LiveRamp Beat Estimates, Digital Turbine Falls Short

May 24th, 2023

Splunk Inc.  (Nasdaq: SPLK), a leading provider of data analytics and monitoring solutions, has released its financial results for the fiscal first quarter of 2024. The company reported non-GAAP earnings per share (EPS) of $0.18, significantly b. Read more

Financial Results Triggering Stock Surges: VNET Group, NVIDIA, Modine Manufacturing, e.l.f. Beauty, Nutanix, Zuora

May 24th, 2023

VNET Group, Inc. (Nasdaq: VNET) has announced its financial results for the first quarter of 2023, exceeding market expectations. The company reported earnings per share (EPS) of $0.06, while the consensus projected a loss of $0.09 per share. This po. Read more

Disappointing Results in Mirati Therapeutics' SAPPHIRE Study and Annexon's ARCHER Trial Lead to Stock Declines

May 24th, 2023

Mirati Therapeutics, Inc. (Nasdaq: MRTX) revealed disappointing news regarding the SAPPHIRE study, as it failed to meet its primary goal of overall survival in the final analysis. The Phase 3 study aimed to assess the effectiveness of sitravatinib, i. Read more

Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.

May 24th, 2023

Washington D.C. / CRWE PRESS RELEASE / May 24, 2023 -  In response to the announcement that Boston Scientific Corporation and non-vascular stent manufacturer M.I. Tech Co., Ltd. have terminated their $230 million purchase agreement, Federal. Read more

NVIDIA Down Before Earnings; Textron, Wave Life Sciences and Shopify Downgraded

May 24th, 2023

NVIDIA Corporation (Nasdaq: NVDA) is scheduled to announce its financial results for the first quarter of fiscal-year 2024 on Wednesday after the closing bell. Market participants are eagerly awaiting this announcement to gain insights into the compa. Read more

Enveric Biosciences Soars on EVM201 Series Potential, Immutep Surges on Clinical Trial Findings, Buy Rating for IDEAYA Biosciences

May 24th, 2023

Enveric Biosciences, Inc. (Nasdaq: ENVB) said that has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for another patent application involving its EVM201 Series The soon-to-issue patent, titled "C4-Carbox. Read more